ERBB2 and large cell carcinoma: The large-cell carcinoma cell line A549 exhibited a moderate activation of the HER1 and IGF-1R pathways with a low activation of the c-MET and HER2 pathways, whereas the metastatic large-cell carcinoma cell line H460 showed only a very low activation of the IGF-1R pathway.